Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. - Wikidata - awgldk - TriplyDB

Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

http://www.wikidata.org/entity/Q54261582

about

Epigenomics of idiopathic pulmonary fibrosis Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers Peripheral blood biomarkers in idiopathic pulmonary fibrosis Molecular biomarkers in idiopathic pulmonary fibrosis Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.Coagulation and autoimmunity in scleroderma interstitial lung disease.Prostaglandin E₂ protects murine lungs from bleomycin-induced pulmonary fibrosis and lung dysfunction.CD8+ T Cell Response to Gammaherpesvirus Infection Mediates Inflammation and Fibrosis in Interferon Gamma Receptor-Deficient Mice Vagotomy attenuates bleomycin-induced pulmonary fibrosis in mice Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis.Molecular and cellular mechanisms of pulmonary fibrosis.Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis.Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement Idiopathic pulmonary fibrosis-an epidemiological and pathological review.CD4+ T lymphocytes in lung fibrosis: diverse subsets, diverse functions.New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis.Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis Idiopathic pulmonary fibrosis and a role for autoimmunity.T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/- mice.Factors influencing oxidative imbalance in pulmonary fibrosis: an immunohistochemical study.Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.Extracorporeal photopheresis in a rat model of pulmonary fibrosis.Immunophenotyping and extracellular matrix remodeling in pulmonary and extrapulmonary sarcoidosis.Temporal evolution of epithelial, vascular and interstitial lung injury in an experimental model of idiopathic pulmonary fibrosis induced by butyl-hydroxytoluene.Idiopathic Pulmonary Fibrosis: Molecular Endotypes of Fibrosis Stratifying Existing and Emerging Therapies.IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity.A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung.Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis.Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.Morphological and molecular markers in idiopathic pulmonary fibrosis

P2860

Q26853673-011B3610-9987-4926-B06F-788240DD0C47 Q26864836-38BDE5F5-BA33-4946-AD0E-EAD9316A20AC Q27000707-17344F75-5F55-49E0-9049-B75E8DE6D8B9 Q27025340-7AC01373-826F-4190-A76C-797287B70981 Q33634521-E987C0C0-DB28-4ADB-AF9D-13AD323950E5 Q33901646-15802703-9D58-4065-BBA0-9BA7F193CA03 Q34770486-661BC7F2-28AA-45E7-9460-2CB01044E288 Q35543612-0B782EC8-2503-42E9-9F1B-82557C1A980B Q35758535-DB2A9C87-2513-4BBB-A366-49FBF579D2C9 Q35972946-76FA9BBD-C029-495F-9D78-A2E8A9706D70 Q36012118-5B49310F-3029-493B-B7C2-ED4910DE2A09 Q36237168-31E683B0-CE95-4D0B-A616-5007ACBA7BC9 Q36743728-3992D742-C48C-4FBE-8A20-CFBF47C9E2C0 Q36976599-3A8E6F09-6371-4360-94A1-206FD478CC94 Q36981609-FDA60613-5A85-4117-8D9F-A1840D5E0044 Q37243946-975D4E96-44F9-47A6-8229-F8683CC58668 Q37393447-D8F2D080-0900-43AC-B127-499C4A88E923 Q37788591-3865643C-D83A-4B9E-A10C-0F618F45AEE7 Q38060461-547DD091-78AD-4D7B-AD49-96E75971F81E Q38153815-CF61F824-1FCC-4432-9808-2003D36BA207 Q38367113-2F62D900-DA6B-4950-86F3-2A38B27D370E Q38654419-B53112D1-2250-44F6-83C0-8CA74CF042E9 Q38737879-7F56ED56-28C6-41FD-B18D-6F2C819727D2 Q42068878-60B2398A-DDA9-4C5D-B104-D29A87165D52 Q42747959-B4F237CF-FA4E-46A8-8B1C-AC14D32AF488 Q43021349-7A7BAD0A-0F6F-4F6B-8DC0-DF14CB2D1041 Q43258294-A7C5F49B-29F0-41BE-BD6F-96D6047BE429 Q43660774-6AD77B31-4111-43FA-A29F-267F99ADC3FA Q46353362-E4B86356-D502-4254-924A-A435085C6F94 Q47901631-ECC44CD0-FEB0-45E7-B258-3A815D2B7786 Q50241267-4D51C2F0-21F7-4C0C-A07D-242261EC1980 Q54391619-C728D5C6-C2AD-4F8A-8791-8FE29BD91913 Q55009120-5619AC92-43A6-42C0-85F5-6CAC00384719 Q55271396-39DBF171-5CBF-4F6B-B32D-E0830DCC45BC Q58004304-5D95A1ED-57BA-4DA3-9CFA-26B4CD823D4B

P2860

Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia.

http://www.wikidata.org/entity/Q54261582

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@en

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@nl

type

label

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@en

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@nl

prefLabel

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@en

Inflammatory cell phenotyping ...... pathic interstitial pneumonia.

@nl

P1433

Q54261582-D92FB170-598F-4B52-9EC0-346DE694CBCF

P1476

Q54261582-EB2197A4-39EC-43AF-95FC-D1A75EBD487F

P2093

Q54261582-27CEED76-A09D-408C-832D-1594C3FCB82D

Q54261582-4BE57BC9-4928-4FF2-AA17-4979C5F17B2C

Q54261582-5DD9DE4D-C23F-40A2-A3A0-453679683661

Q54261582-640E291D-A59D-4FA4-ADB8-FEDA0FADB8F7

P2860

Q54261582-1D8ADE6B-FD65-4129-B0DC-D31E9126D4BD

Q54261582-2346FB00-CF57-43AD-AD07-F3CD76604329

Q54261582-4FFB45AC-8247-4724-80A8-9B181A2710AC

Q54261582-56BB3729-991B-4E37-BA99-20D23554A22B

Q54261582-6DE004FB-D32D-4D47-BE6F-631D79B110BE

Q54261582-ACC3C70E-E7B1-4EC8-BEBA-148C3DA7BD82

Q54261582-B3D2B4B4-C3E7-4AA2-BC7E-05DD132228DD

Q54261582-B7C7EC47-4B6A-4B18-8AD6-29D7EA6C509D

Q54261582-BB2C5488-7C1C-4127-968D-84F8B6590429

Q54261582-CDE0CA31-09F9-41F6-9B95-E48C14EE160B

P304

Q54261582-B0DB975E-605F-4A8A-8797-315C602C0EFB

P31

Q54261582-13EA765E-359A-4092-9FA1-2C0369A92AFE

P356

Q54261582-22AB8C6B-D623-4D27-944B-55B89D16F5F6

P433

Q54261582-C2846FA5-B564-48EE-B7D0-43A1B38AB464

P478

Q54261582-537FE383-48E0-475B-A388-51814ADF721E

P50

Q54261582-39593740-067B-4B25-AD6F-70EA3870087B

P577

Q54261582-DE9AD036-2B4E-4065-AAB6-19FBF3E672B1

P5875

Q54261582-3A7119B5-A9BD-46C2-B230-6F9D8823C513

P698

Q54261582-3DEE7E03-A714-4364-ACC0-F1D942662380

P921

Q54261582-68E512DD-CC92-4BC4-95CA-9AFBCC6BC6A5

Q54261582-F50E47D9-C9EA-4234-B94B-46FF02D30160

P356

P1433

P1476

Inflammatory cell phenotyping ...... opathic interstitial pneumonia

@en

P2093

Carlos Roberto Ribeiro de Carvalho

http://www.w3.org/2001/XMLSchema#string

Edwin Roger Parra

http://www.w3.org/2001/XMLSchema#string

Esmeralda Eher

http://www.w3.org/2001/XMLSchema#string

Vera Luiza Capelozzi

http://www.w3.org/2001/XMLSchema#string

P2860

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Points of control in inflammation

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification.

The expanding universe of T-cell subsets: Th1, Th2 and more.

A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.

Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring.

Systemic immune cell activation in a subgroup of patients with idiopathic pulmonary fibrosis.

Cell profiles of bronchoalveolar lavage fluid as prognosticators of idiopathic pulmonary fibrosis/usual interstitial pneumonia among Japanese Patients.

Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia.

P304

159-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000097133

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Ronaldo Adib Kairalla

P577

2006-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6688558

http://www.w3.org/2001/XMLSchema#string

P698

17108669

http://www.w3.org/2001/XMLSchema#string

P921